DSE: IBNSINA Statistics

Total Valuation

The IBN SINA Pharmaceutical Industry has a market cap or net worth of BDT 9.05 billion. The enterprise value is 10.29 billion.

Market Cap	9.05B
Enterprise Value	10.29B

Important Dates

The next estimated earnings date is Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Oct 28, 2024

Share Statistics

The IBN SINA Pharmaceutical Industry has 31.24 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	31.24M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	44.31%
Float	n/a

Valuation Ratios

The trailing PE ratio is 15.28.

PE Ratio	15.28
Forward PE	n/a
PS Ratio	0.81
PB Ratio	2.52
P/TBV Ratio	2.52
P/FCF Ratio	155.26
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.08, with an EV/FCF ratio of 176.58.

EV / Earnings	17.37
EV / Sales	0.92
EV / EBITDA	6.08
EV / EBIT	12.30
EV / FCF	176.58

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.45.

Current Ratio	1.15
Quick Ratio	0.30
Debt / Equity	0.45
Debt / EBITDA	0.97
Debt / FCF	28.28
Interest Coverage	13.92

Financial Efficiency

Return on equity (ROE) is 17.34% and return on invested capital (ROIC) is 10.74%.

Return on Equity (ROE)	17.34%
Return on Assets (ROA)	8.68%
Return on Capital (ROIC)	10.74%
Revenue Per Employee	2.67M
Profits Per Employee	141,026
Employee Count	4,200
Asset Turnover	1.86
Inventory Turnover	4.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.05%
50-Day Moving Average	298.52
200-Day Moving Average	280.28
Relative Strength Index (RSI)	47.44
Average Volume (20 Days)	54,327

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, The IBN SINA Pharmaceutical Industry had revenue of BDT 11.23 billion and earned 592.31 million in profits. Earnings per share was 18.96.

Revenue	11.23B
Gross Profit	4.45B
Operating Income	836.69M
Pretax Income	812.66M
Net Income	592.31M
EBITDA	1.67B
EBIT	836.69M
Earnings Per Share (EPS)	18.96

Full Income Statement

Balance Sheet

The company has 411.73 million in cash and 1.65 billion in debt, giving a net cash position of -1.21 billion or -38.60 per share.

Cash & Cash Equivalents	411.73M
Total Debt	1.65B
Net Cash	-1.21B
Net Cash Per Share	-38.60
Equity (Book Value)	3.62B
Book Value Per Share	114.80
Working Capital	315.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 704.78 million and capital expenditures -646.50 million, giving a free cash flow of 58.28 million.

Operating Cash Flow	704.78M
Capital Expenditures	-646.50M
Free Cash Flow	58.28M
FCF Per Share	1.87

Full Cash Flow Statement

Margins

Gross margin is 39.63%, with operating and profit margins of 7.45% and 5.27%.

Gross Margin	39.63%
Operating Margin	7.45%
Pretax Margin	7.24%
Profit Margin	5.27%
EBITDA Margin	14.84%
EBIT Margin	7.45%
FCF Margin	0.52%

Dividends & Yields

This stock pays an annual dividend of 6.30, which amounts to a dividend yield of 2.18%.

Dividend Per Share	6.30
Dividend Yield	2.18%
Dividend Growth (YoY)	5.00%
Years of Dividend Growth	n/a
Payout Ratio	30.19%
Buyback Yield	n/a
Shareholder Yield	2.18%
Earnings Yield	6.55%
FCF Yield	0.64%

Dividend Details

Stock Splits

The last stock split was on October 23, 2018. It was a forward split with a ratio of 1.1.

Last Split Date	Oct 23, 2018
Split Type	Forward
Split Ratio	1.1

Scores

The IBN SINA Pharmaceutical Industry has an Altman Z-Score of 4.76.

Altman Z-Score	4.76
Piotroski F-Score	n/a